- Filed
- Nov 8, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Nov 3, 2022 | 12.96M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2022 | 12.96M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2022 | 12.94M sh |
| Shares Diluted restated | Q3 2022 · Sep 30, 2021 | 12.71M sh |
| Shares Diluted restated | Q3 2022 · Sep 30, 2021 | 11.93M sh |
| Capex | Q3 2022 · Sep 30, 2022 | $2.84K |
| Capex | Q3 2022 · Sep 30, 2021 | $9.85K |
| Operating Cash Flow | Q3 2022 · Sep 30, 2022 | −$27.5M |
| Operating Cash Flow | Q3 2022 · Sep 30, 2021 | −$21.51M |
| Long Term Debt | Q3 2022 · Sep 30, 2022 | $15.74M |
| Short Term Debt | Q3 2022 · Sep 30, 2022 | $2.65M |
| Cash And Equivalents | Q3 2022 · Sep 30, 2022 | $15.86M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2021 | $46.99M |
| Cash And Equivalents | Q3 2022 · Sep 30, 2021 | $53.61M |
| Stockholders Equity | Q3 2022 · Sep 30, 2022 | $13.46M |
| Stockholders Equity | Q3 2022 · Jun 30, 2022 | $22.09M |
| Stockholders Equity | Q3 2022 · Mar 31, 2022 | $30.94M |
| Stockholders Equity | Q3 2022 · Dec 31, 2021 | $41.6M |
| Stockholders Equity | Q3 2022 · Sep 30, 2021 | $49.27M |
| Stockholders Equity | Q3 2022 · Jun 30, 2021 | $59.14M |
| Stockholders Equity | Q3 2022 · Mar 31, 2021 | $34.07M |
| Stockholders Equity | Q3 2022 · Dec 31, 2020 | $32.14M |
| Current Liabilities | Q3 2022 · Sep 30, 2022 | $12.86M |
| Current Liabilities | Q3 2022 · Dec 31, 2021 | $8.46M |
| Total Liabilities | Q3 2022 · Sep 30, 2022 | $28.67M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $8.57M |
| Current Assets | Q3 2022 · Sep 30, 2022 | $18.45M |
| Current Assets | Q3 2022 · Dec 31, 2021 | $49.99M |
| Total Assets | Q3 2022 · Sep 30, 2022 | $42.14M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $50.17M |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$0.72 |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$2.46 |
| Eps Diluted restated | Q3 2022 · Sep 30, 2021 | −$1.06 |
| Eps Diluted restated | Q3 2022 · Sep 30, 2021 | −$2.28 |
| Eps Basic | Q3 2022 · Sep 30, 2022 | −$0.72 |
| Eps Basic | Q3 2022 · Sep 30, 2022 | −$2.46 |
| Eps Basic restated | Q3 2022 · Sep 30, 2021 | −$1.06 |
| Eps Basic restated | Q3 2022 · Sep 30, 2021 | −$2.28 |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $2.42M |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $9.06M |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $2.39M |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $7.15M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$9.35M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$31.84M |
| Net Income | Q3 2022 · Jun 30, 2022 | −$11.13M |
| Net Income | Q3 2022 · Mar 31, 2022 | −$11.35M |
| Net Income | Q3 2022 · Sep 30, 2021 | −$13.54M |
| Net Income | Q3 2022 · Sep 30, 2021 | −$27.22M |
| Net Income | Q3 2022 · Jun 30, 2021 | −$8.25M |
| Net Income | Q3 2022 · Mar 31, 2021 | −$5.43M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$8.72M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$31.28M |
| Operating Income | Q3 2022 · Sep 30, 2021 | −$13.54M |
| Operating Income | Q3 2022 · Sep 30, 2021 | −$27.2M |